2-piperidone has been researched along with Acute Lymphoid Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akahane, K; Chang, Y; Chepyala, D; Fischer, M; Gao, Q; Ghate, PS; Goto, H; High, AA; Iacobucci, I; Keramatnia, F; Mishra, A; Mullighan, CG; Nishiguchi, G; Peng, J; Rankovic, Z; Yang, JJ; Yang, L | 1 |
1 other study(ies) available for 2-piperidone and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia.
Topics: Antineoplastic Agents; Child; Humans; Isoindoles; Piperidones; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2023 |